TYMS and colorectal carcinoma: As inhibition of TYMS expression is emerging as a promising molecular strategy to improve the therapeutic sensitivity of 5-FU, it is expected to increase the treatment efficiency of CRC through the production of NaB, which is naturally made from dietary fiber by gut microbiota.